시장보고서

상품코드

1790320

분자생물학용 효소, 키트, 시약 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Molecular Biology Enzymes, Reagents And Kits Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Enzymes), By Application (Cloning, Sequencing), By End Use (Academic & Research), By Region, And Segment Forecasts, 2025 - 2033

발행일: 2025년 07월 | 리서치사:

Grand View Research | 페이지 정보: 영문 275 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

분자생물학용 효소·키트·시약 시장 개요

세계의 DNA 메틸화 시장 규모는 2023년에 14억 7,000만 달러로 평가되며, 2025-2033년에 CAGR 9.99%로 성장하며, 2030년에는 341억 1,000만 달러에 달할 것으로 예측됩니다. 시장 확대의 원동력은 특히 제약 및 생명공학 연구 등 광범위한 분자생물학적 용도에서 이들 제품의 채택이 확대되고 있다는 점입니다.

정밀진단, 의약품 개발, 유전체 분석에 대한 관심이 높아지면서 신뢰할 수 있고 효율적인 분자 툴에 대한 수요가 계속 증가하고 있습니다. 생명과학 연구에 대한 투자 증가와 분자 검사 플랫폼의 가용성 확대는 시장 성장을 더욱 촉진하고 있습니다. 특히 자동화 및 고처리량 워크플로우에 대한 중요성이 높아지면서 학술 및 상업용 실험실 모두에서 첨단 키트, 시약 및 효소의 채택이 증가하고 있습니다.

시퀀싱 기술의 적용 확대로 유전체학과 분자생물학은 크게 변모하여 높은 정확도와 효율적인 연구가 가능해졌습니다. 차세대 염기서열 분석(NGS)의 등장으로 DNA 염기서열 분석은 더욱 친숙하고 비용 효율적이 되었으며, 3세대 플랫폼은 유전체 조립, 하프로유형 위상 분석, 구조적 변이 분석의 과제를 해결하고 있습니다. 시퀀싱 솔루션에 대한 수요 증가는 첨단 연구를 지원하는 특수 시약 및 키트의 지속적인 개발로 이어졌습니다. 2024년 11월, 캘리포니아주 공중보건국(CDPH)은 실험실 검사를 통해 미국 최초의 수두 사례를 확인했습니다. 이 사례는 PCR을 통해 확인되었고, 염기서열 분석으로 확진되었습니다. 이 사례는 신속하고 정확한 분자진단의 중요성을 강조하고, 첨단 PCR 및 염기서열 분석 툴의 채택을 촉진하여 분자생물학적 효소, 시약 및 키트 시장의 성장을 지원하고 있습니다.

이러한 발전에도 불구하고 데이터 보안과 스토리지 인프라에 대한 우려는 여전히 과제로 남아있습니다. 시퀀싱을 통해 생성된 방대한 데이터세트에는 민감한 유전정보가 포함되어 있으므로 윤리적인 취급과 안전한 보관이 필요하며, 이는 대부분 클라우드 기반 기술을 통해 이루어집니다. 신흥 국가에서는 고급 데이터 스토리지 솔루션에 대한 접근성이 제한되어 있으며, 시퀀싱 툴의 광범위한 도입을 방해하고 시장에 간접적인 영향을 미칠 수 있습니다. 그러나 정부 주도의 바이오뱅크 설립 노력과 국가 유전체 프로젝트는 이러한 우려를 일부 완화하고 장기적인 발전을 지원할 것으로 기대됩니다.

용도 시장 점유율, 2024년과 2033년
부문 대시보드
세계의 분자생물학용 효소·키트·시약 시장 : 용도별 전망
2021-2033년 시장 규모와 예측과 동향 분석
- 클론
- 시퀀스
- PCR
- 에피제네틱스
- 유전자형 판정
- RCA/MDA
- RNA Therapeutics
- 전사체학
- 단백질체학
- 액체생검
- 기타

제6장 분자생물학용 효소·키트·시약 시장 : 최종 용도별, 추정·동향 분석

최종 용도 시장 점유율, 2024년과 2033년
부문 대시보드
세계의 분자생물학용 효소·키트·시약 시장 : 최종 용도별 전망
2021-2033년 시장 규모와 예측과 동향 분석
- 제약 바이오테크놀러지
- 학술연구
- 병원 & 진단
- 기타

제7장 분자생물학용 효소·키트·시약 시장 : 지역별 비즈니스 분석

지역 시장 스냅숏
북미
유럽
아시아태평양

KSA 25.08.26

Molecular Biology Enzymes, Reagents And Kits Market Summary

The global DNA methylation market size was valued at USD 1.47 billion in 2023 and is projected to reach USD 34.11 billion by 2030, growing at a CAGR of 9.99% from 2025 to 2033. Market expansion is driven by the growing adoption of these products across a wide range of molecular biology applications, particularly in pharmaceutical and biotechnology research.

Increasing focus on precision diagnostics, drug development, and genomic analysis continues to support the demand for reliable and efficient molecular tools. Rising investments in life sciences research and the expanding availability of molecular testing platforms are further supporting market growth. In particular, the growing emphasis on automation and high-throughput workflows is encouraging the adoption of advanced kits, reagents, and enzymes across both academic and commercial laboratories.

The expanding application of sequencing technologies has significantly transformed genomics and molecular biology, enabling highly accurate and efficient research. The emergence of next-generation sequencing (NGS) has made DNA sequencing more accessible and cost-effective, while third-generation platforms are addressing challenges in genome assembly, haplotype phasing, and structural variation analysis. The rising demand for sequencing solutions has led to the continuous development of specialized reagents and kits that support advanced research. In November 2024, the California Department of Public Health (CDPH) confirmed the first case of clade I mpox in the U.S. through laboratory testing. The case, identified via PCR and confirmed through further sequencing, highlights the importance of rapid and precise molecular diagnostics, driving the adoption of advanced PCR and sequencing tools and supporting the growth of the molecular biology enzymes, reagents, and kits market.

Despite these advances, data security and storage infrastructure concerns pose a challenge. The massive datasets generated through sequencing contain sensitive genetic information, requiring ethical handling and secure storage, often through cloud-based technologies. In emerging economies, limited access to high-end data storage solutions may hinder the broader adoption of sequencing tools, indirectly affecting the market. However, government-led efforts to establish biobanks and national genome initiatives are expected to mitigate some of these concerns and support long-term market development.

Global Molecular Biology Enzymes, Reagents And Kits Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global molecular biology enzymes, reagents, and kits market report based on product, application, end use, and region:

Product Outlook (Revenue, USD Million, 2021 - 2033)
Kits & Reagents
PCR Kits
qPCR Kits
RT-PCR Kits
Library Preparation Kits
Cloning Kits
Purification Kits
Gene Editing Kits
Other Kits
Enzymes
Polymerases
- DNA Polymerases
High Fidelity DNA Polymerases
Pfu DNA Polymerases
Phusion DNA Polymerases
Hot Start DNA Polymerases
Taq DNA Polymerases High Fidelity
Others
Thermostable DNA Polymerases
Standard Taq DNA Polymerases
Tth DNA Polymerases
Others
Strand-displacing DNA Polymerases
Bst DNA Polymerases
Phi29 DNA Polymerases
Others
- RNA Polymerases
T7 RNA Polymerase
SP6 RNA Polymerase
T3 RNA Polymerase
Other RNA Polymerase
Reverse Transcriptase (RTs)
- M-MLV RT
- AMV RT
- Thermostable RT
- Template Switch
- TGIRT
- Induro
- MarathonRT
Ligases
- DNA Ligases
T4 DNA Ligases
E coli DNA Ligase
Taq DNA Ligase
Others
- RNA Ligases
Nucleases
- DNase I
- RNase A, RNase H
- Nickases
- Restriction Nucleases
- TdTs
Endonucleases
- EndoQ
- AP Nuclease
Kinases
Phosphatases
CRISPR-associated Enzymes
Cas9
Cas12a (Cpf1)
Cas13
Specialty Enzymes
Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
Cloning
Pharma & Biotech
- Research
- Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Sequencing
Pharma & Biotech
- Research
- Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
PCR
Pharma & Biotech
- Research
- Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Epigenetics
Pharma & Biotech
- Research
- Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Genotyping
Pharma & Biotech
- Research
- Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
RCA/MDA
Pharma & Biotech
- Research
- Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
RNA Therapeutics
Pharma & Biotech
- Research
- Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Transcriptomics
Pharma & Biotech
- Research
- Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Proteomics
Pharma & Biotech
- Research
- Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Liquid Biopsy
Pharma & Biotech
- Research
- Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Other Applications
Pharma & Biotech
- Research
- Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Molecular Biology Enzymes, Reagents and Kits Market: Methodology and Scope

1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
  - 1.1.1.1. Product Segment
  - 1.1.1.2. Application Segment
  - 1.1.1.3. End use segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
- 1.4.1. Objective - 1
- 1.4.2. Objective - 2
- 1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
1.7. Information or Data Analysis
- 1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
- 1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations

Chapter 2. Molecular Biology Enzymes, Reagents and Kits Market: Executive Summary

2.1. Market Snapshot
2.2. Product and Application Snapshot
2.3. End use Snapshot
2.4. Competitive Landscape Snapshot

Chapter 3. Molecular Biology Enzymes, Reagents and Kits Market Variables, Trends, & Scope

3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
- 3.2.1. Parent Market Outlook
- 3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraint Analysis
3.4. Porter's Five Forces Analysis
3.5. PESTLE Analysis

Chapter 4. Molecular Biology Enzymes, Reagents and Kits Market: Product Estimates & Trend Analysis

4.1. Product Market Share, 2024 & 2033
4.2. Segment Dashboard
4.3. Global Molecular Biology Enzymes, Reagents And Kits Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 4.4.1. Kits & Reagents
  - 4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.1.2. PCR Kits
    - 4.4.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.1.3. qPCR Kits
    - 4.4.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.1.4. RT-PCR Kits
    - 4.4.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.1.5. Library Preparation Kits
    - 4.4.1.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.1.6. Cloning Kits
    - 4.4.1.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.1.7. Purification Kits
    - 4.4.1.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.1.8. Gene Editing Kits
    - 4.4.1.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.1.9. Other Kits
    - 4.4.1.9.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.2. Enzymes
  - 4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.2.2. Polymerases
    - 4.4.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 4.4.2.2.2. DNA Polymerases
      - 4.4.2.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      - 4.4.2.2.2.2. High Fidelity DNA Polymerases
        
        4.4.2.2.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
        4.4.2.2.2.2.2. Pfu DNA Polymerases
  - 4.4.2.2.2.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.2.2.2.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.2.2.2.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.2.2.2.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 4.4.2.2.3. RNA Polymerases
      - 4.4.2.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      - 4.4.2.2.3.2. T7 RNA Polymerase
        
        4.4.2.2.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      - 4.4.2.2.3.3. SP6 RNA Polymerase
        
        4.4.2.2.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      - 4.4.2.2.3.4. T3 RNA Polymerase
        
        4.4.2.2.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      - 4.4.2.2.3.5. Other RNA Polymerase
        
        4.4.2.2.3.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.2.3. Reverse Transcriptase (RTs)
    - 4.4.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 4.4.2.3.2. M-MLV RT
      - 4.4.2.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 4.4.2.3.3. AMV RT
      - 4.4.2.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 4.4.2.3.4. Thermostable RT
      - 4.4.2.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 4.4.2.3.5. Template Switch
      - 4.4.2.3.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 4.4.2.3.6. TGIRT
      - 4.4.2.3.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 4.4.2.3.7. Induro
      - 4.4.2.3.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 4.4.2.3.8. MarathonRT
      - 4.4.2.3.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.2.4. Ligases
    - 4.4.2.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 4.4.2.4.2. DNA Ligases
      - 4.4.2.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      - 4.4.2.4.2.2. T4 DNA Ligases
      - 4.4.2.4.2.3. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.2.4.2.3.1.
    - 4.4.2.4.3. RNA Ligases
      - 4.4.2.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.2.5. Nucleases
    - 4.4.2.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 4.4.2.5.2. DNase I
      - 4.4.2.5.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 4.4.2.5.3. RNase A, RNase H
      - 4.4.2.5.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 4.4.2.5.4. Nickases
      - 4.4.2.5.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 4.4.2.5.5. Restriction Nucleases
      - 4.4.2.5.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 4.4.2.5.6. TdTs
      - 4.4.2.5.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.2.6. Endonucleases
    - 4.4.2.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 4.4.2.6.2. EndoQ
      - 4.4.2.6.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 4.4.2.6.3. AP Nuclease
      - 4.4.2.6.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.2.7. Kinases
    - 4.4.2.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.2.8. Phosphatases
    - 4.4.2.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.2.9. CRISPR-associated Enzymes
    - 4.4.2.9.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 4.4.2.9.2. Cas9
      - 4.4.2.9.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 4.4.2.9.3. Cas12a (Cpf1)
      - 4.4.2.9.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 4.4.2.9.4. Cas13
      - 4.4.2.9.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.2.10. Specialty Enzymes
    - 4.4.2.10.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 4.4.2.11. Others
    - 4.4.2.11.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Molecular Biology Enzymes, Reagents and Kits Market: Application Estimates & Trend Analysis

5.1. Application Market Share, 2024 & 2033
5.2. Segment Dashboard
5.3. Global Molecular Biology Enzymes, Reagents And Kits Market by Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 5.4.1. Cloning
  - 5.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.1.2. Pharma & Biotech
    - 5.4.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.1.2.2. Research
      - 5.4.1.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.1.2.3. Therapeutics/Production
      - 5.4.1.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.1.3. Academic & Research
    - 5.4.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.1.4. Hospital & Diagnostics
    - 5.4.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.1.5. Others
    - 5.4.1.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.2. Sequencing
  - 5.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.2.2. Pharma & Biotech
    - 5.4.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.2.2.2. Research
      - 5.4.2.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.2.2.3. Therapeutics/Production
      - 5.4.2.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.2.3. Academic & Research
    - 5.4.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.2.4. Hospital & Diagnostics
    - 5.4.2.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.2.5. Others
    - 5.4.2.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.3. PCR
  - 5.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.3.2. Pharma & Biotech
    - 5.4.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.3.2.2. Research
      - 5.4.3.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.3.2.3. Therapeutics/Production
      - 5.4.3.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.3.3. Academic & Research
    - 5.4.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.3.4. Hospital & Diagnostics
    - 5.4.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.3.5. Others
    - 5.4.3.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.4. Epigenetics
  - 5.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.4.2. Pharma & Biotech
    - 5.4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.4.2.2. Research
      - 5.4.4.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.4.2.3. Therapeutics/Production
      - 5.4.4.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.4.3. Academic & Research
    - 5.4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.4.4. Hospital & Diagnostics
    - 5.4.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.4.5. Others
    - 5.4.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.5. Genotyping
  - 5.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.5.2. Pharma & Biotech
    - 5.4.5.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.5.2.2. Research
      - 5.4.5.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.5.2.3. Therapeutics/Production
      - 5.4.5.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.5.3. Academic & Research
    - 5.4.5.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.5.4. Hospital & Diagnostics
    - 5.4.5.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.5.5. Others
    - 5.4.5.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.6. RCA/MDA
  - 5.4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.6.2. Pharma & Biotech
    - 5.4.6.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.6.2.2. Research
      - 5.4.6.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.6.2.3. Therapeutics/Production
      - 5.4.6.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.6.3. Academic & Research
    - 5.4.6.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.6.4. Hospital & Diagnostics
    - 5.4.6.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.6.5. Others
    - 5.4.6.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.7. RNA Therapeutics
  - 5.4.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.7.2. Pharma & Biotech
    - 5.4.7.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.7.2.2. Research
      - 5.4.7.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.7.2.3. Therapeutics/Production
      - 5.4.7.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.7.3. Academic & Research
    - 5.4.7.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.7.4. Hospital & Diagnostics
    - 5.4.7.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.7.5. Others
    - 5.4.7.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.8. Transcriptomics
  - 5.4.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.8.2. Pharma & Biotech
    - 5.4.8.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.8.2.2. Research
      - 5.4.8.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.8.2.3. Therapeutics/Production
      - 5.4.8.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.8.3. Academic & Research
    - 5.4.8.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.8.4. Hospital & Diagnostics
    - 5.4.8.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.8.5. Others
    - 5.4.8.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.9. Proteomics
  - 5.4.9.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.9.2. Pharma & Biotech
    - 5.4.9.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.9.2.2. Research
      - 5.4.9.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.9.2.3. Therapeutics/Production
      - 5.4.9.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.9.3. Academic & Research
    - 5.4.9.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.9.4. Hospital & Diagnostics
    - 5.4.9.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.9.5. Others
    - 5.4.9.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.10. Liquid Biopsy
  - 5.4.10.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.10.2. Pharma & Biotech
    - 5.4.10.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.10.2.2. Research
      - 5.4.10.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.10.2.3. Therapeutics/Production
      - 5.4.10.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.10.3. Academic & Research
    - 5.4.10.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.10.4. Hospital & Diagnostics
    - 5.4.10.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.10.5. Others
    - 5.4.10.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.11. Other Applications
  - 5.4.11.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.11.2. Pharma & Biotech
    - 5.4.11.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.11.2.2. Research
      - 5.4.11.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    - 5.4.11.2.3. Therapeutics/Production
      - 5.4.11.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.11.3. Academic & Research
    - 5.4.11.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.11.4. Hospital & Diagnostics
    - 5.4.11.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 5.4.11.5. Others
    - 5.4.11.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Molecular Biology Enzymes, Reagents and Kits Market: End use Estimates & Trend Analysis

6.1. End use Market Share, 2024 & 2033
6.2. Segment Dashboard
6.3. Global Molecular Biology Enzymes, Reagents And Kits Market by End use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 6.4.1. Pharma & Biotech
  - 6.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 6.4.1.2. Research
    - 6.4.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  - 6.4.1.3. Therapeutics/Production
    - 6.4.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.4.2. Academic & Research
  - 6.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.4.3. Hospital & Diagnostics
  - 6.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.4.4. Other
  - 6.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Molecular Biology Enzymes, Reagents and Kits Market: Regional Business Analysis

7.1. Regional Market Snapshot
7.2. North America
- 7.2.1. North America Molecular Biology Enzymes, Reagents and Kits Market Estimates And Forecast, 2021 - 2033 (USD Million)
- 7.2.2. U.S.
  - 7.2.2.1. U.S. Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
  - 7.2.2.2. Key Country Dynamics
  - 7.2.2.3. Regulatory Framework
  - 7.2.2.4. Reimbursement Scenario
  - 7.2.2.5. Competitive Scenario
- 7.2.3. Canada
  - 7.2.3.1. Canada Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
  - 7.2.3.2. Key Country Dynamics
  - 7.2.3.3. Regulatory Framework
  - 7.2.3.4. Reimbursement Scenario
  - 7.2.3.5. Competitive Scenario
- 7.2.4. Mexico
  - 7.2.4.1. Mexico Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
  - 7.2.4.2. Key Country Dynamics
  - 7.2.4.3. Regulatory Framework
  - 7.2.4.4. Reimbursement Scenario
  - 7.2.4.5. Competitive Scenario
7.3. Europe
- 7.3.1. Europe Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
- 7.3.2. UK
  - 7.3.2.1. UK Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
  - 7.3.2.2. Key Country Dynamics
  - 7.3.2.3. Regulatory Framework
  - 7.3.2.4. Reimbursement Scenario
  - 7.3.2.5. Competitive Scenario
- 7.3.3. Germany
  - 7.3.3.1. Germany Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
  - 7.3.3.2. Key Country Dynamics
  - 7.3.3.3. Regulatory Framework
  - 7.3.3.4. Reimbursement Scenario
  - 7.3.3.5. Competitive Scenario
- 7.3.4. Spain
  - 7.3.4.1. Spain Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
  - 7.3.4.2. Key Country Dynamics
  - 7.3.4.3. Regulatory Framework
  - 7.3.4.4. Reimbursement Scenario
  - 7.3.4.5. Competitive Scenario
- 7.3.5. France
  - 7.3.5.1. France Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
  - 7.3.5.2. Key Country Dynamics
  - 7.3.5.3. Regulatory Framework
  - 7.3.5.4. Reimbursement Scenario
  - 7.3.5.5. Competitive Scenario
- 7.3.6. Italy
  - 7.3.6.1. Italy Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
  - 7.3.6.2. Key Country Dynamics
  - 7.3.6.3. Regulatory Framework
  - 7.3.6.4. Reimbursement Scenario
  - 7.3.6.5. Competitive Scenario
- 7.3.7. Denmark
  - 7.3.7.1. Denmark Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
  - 7.3.7.2. Key Country Dynamics
  - 7.3.7.3. Regulatory Framework
  - 7.3.7.4. Reimbursement Scenario
  - 7.3.7.5. Competitive Scenario
- 7.3.8. Sweden
  - 7.3.8.1. Sweden Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
  - 7.3.8.2. Key Country Dynamics
  - 7.3.8.3. Regulatory Framework
  - 7.3.8.4. Reimbursement Scenario
  - 7.3.8.5. Competitive Scenario
- 7.3.9. Norway
  - 7.3.9.1. Norway Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
  - 7.3.9.2. Key Country Dynamics
  - 7.3.9.3. Regulatory Framework
  - 7.3.9.4. Reimbursement Scenario
  - 7.3.9.5. Competitive Scenario
7.4. Asia Pacific
- 7.4.1. Asia-Pacific Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
- 7.4.2. Japan
  - 7.4.2.1. Japan Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
  - 7.4.2.2. Key Country Dynamics
  - 7.4.2.3. Regulatory Framework
  - 7.4.2.4. Reimbursement Scenario
  - 7.4.2.5. Competitive Scenario
- 7.4.3. China
  - 7.4.3.1. China Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
  - 7.4.3.2. Key Country Dynamics
  - 7.4.3.3. Regulatory Framework
  - 7.4.3.4. Reimbursement Scenario
  - 7.4.3.5. Competitive Scenario
- 7.4.4. India
  - 7.4.4.1. India Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
  - 7.4.4.2. Key Country Dynamics
  - 7.4.4.3. Regulatory Framework
  - 7.4.4.4. Reimbursement Scenario
  - 7.4.4.5. Competitive Scenario
- 7.4.5. South Korea
  - 7.4.5.1. South Korea Molecular Biology Enzymes, Reagents and Kits Market, 202

분자생물학용 효소, 키트, 시약 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Molecular Biology Enzymes, Reagents And Kits Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Enzymes), By Application (Cloning, Sequencing), By End Use (Academic & Research), By Region, And Segment Forecasts, 2025 - 2033

목차

제1장 분자생물학용 효소·키트·시약 시장 : 조사 방법과 범위

제2장 분자생물학용 효소·키트·시약 시장 : 개요

제3장 분자생물학용 효소·키트·시약 시장 변수, 동향, 범위

제4장 분자생물학용 효소·키트·시약 시장 : 제품별, 추정·동향 분석

제5장 분자생물학용 효소·키트·시약 시장 : 용도별, 추정·동향 분석